Home
Clinical Resources Search
PQI: Sacituzumab govitecan-hziy (Trodelvy®): Prophylaxis and Management of Adverse Events

Sacituzumab govitecan-hziy (Trodelvy®): Prophylaxis and Management of Adverse Events

Download PQI pdf 0.28MB

Last Updated: May 2, 2025

By: Rebecca Martin, PharmD, BCOP

About this PQI

The purpose of this PQI is to provide information on the management of common adverse events of sacituzumab govitecan-hziy including diarrhea and neutropenia, as well as prophylaxis of nausea and vomiting.

More About This PQI

PQI in Action Articles:

Sacituzumab_trodelvy_Diarrhea pdf 1.55MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Diarrhea Nausea & Vomiting (N/V) Sacituzumab govitecan Trodelvy

PQI

Frequently Searched

Supported by

Sacituzumab govitecan-hziy (Trodelvy®): Prophylaxis and Management of Adverse Events

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers

PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)

PQI: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI: Ibrutinib Dosing Optimization

PQI in Action: Larotrectinib (Vitrakvi®) Overview

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

S8 Ep 13: Supporting Patients Through Financial Assistance

S8 Bonus Episode: ¡No Más Melanomas! – Updates in the Treatment of Cutaneous Melanoma

S8 Ep 12: Lorlatinib in Practice: 5 Years of Data, Real-World Counseling, and AE Management

S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Telotristat Ethyl (Xermelo®) for the Management of Carcinoid Syndrome Diarrhea

PQI: Oncolytic Induced Diarrhea

PQI in Action: Telotristat Ethyl: Carcinoid Syndrome Diarrhea

PQI: Olanzapine (Zyprexa®) In Chemotherapy Induced Nausea and Vomiting

PQI: Netupitant/Fosnetupitant and Palonosetron (Akynzeo®) for Chemotherapy-Induced Nausea and Vomiting

PQI: Granisetron Transdermal System (Sancuso®) for Chemotherapy Induced Nausea and Vomiting

PQI: Chemotherapy-Induced Nausea and Vomiting

PQI in Action: Sacituzumab Govitecan (Trodelvy®): Management of Neutropenia and Diarrhea

PQI in Action: Sacituzumab Govitecan (Trodelvy®): Management of Neutropenia and Diarrhea

PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers

PQI in Action: Larotrectinib (Vitrakvi®) Overview

PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)

S8 Ep 13: Supporting Patients Through Financial Assistance